DCF — VALLEY BAPTIST MED CNTR BROWNSVILLE
Enterprise Value: $129.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$129.0M
Enterprise Value
$32.8M
PV of Cash Flows
$96.2M
PV of Terminal Value
$154.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $208.5M | $17.7M | 8.0% | $5.8M | $5.2M |
| Year 2 | $214.8M | $20.4M | 9.0% | $7.6M | $6.2M |
| Year 3 | $221.2M | $23.2M | 10.0% | $9.4M | $7.1M |
| Year 4 | $227.8M | $25.1M | 11.0% | $10.6M | $7.2M |
| Year 5 | $234.7M | $26.4M | 11.0% | $11.3M | $7.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $129.0M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$202.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999940719367
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5